Matches in Wikidata for { <http://www.wikidata.org/entity/Q63338654> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q63338654 description "clinical trial" @default.
- Q63338654 description "ensayu clínicu" @default.
- Q63338654 description "klinisch onderzoek" @default.
- Q63338654 description "клінічне випробування" @default.
- Q63338654 name "Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer" @default.
- Q63338654 type Item @default.
- Q63338654 label "Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer" @default.
- Q63338654 prefLabel "Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer" @default.
- Q63338654 P1132 Q63338654-03D509B0-09B5-4A7A-AB56-6A028912861C @default.
- Q63338654 P1476 Q63338654-3E3D2AD9-005C-4EF0-8586-84725FDC4F87 @default.
- Q63338654 P17 Q63338654-5066293A-470F-4EE8-A42C-C9048620C5C7 @default.
- Q63338654 P17 Q63338654-A4A21E35-63BC-4C38-8C0F-14CAC44B82B3 @default.
- Q63338654 P2899 Q63338654-CF3E1BCF-C0DE-4398-BB1E-ACEE3D86C36C @default.
- Q63338654 P3098 Q63338654-E563B364-DC10-470F-9854-E3C4BF474F46 @default.
- Q63338654 P31 Q63338654-AD7491AB-8AFA-4F49-BA1E-46838F58389E @default.
- Q63338654 P4844 Q63338654-6FEFADAE-BEBE-4FC3-B48C-055A00D211D9 @default.
- Q63338654 P4844 Q63338654-B6F5F102-5E19-4629-93F7-E54AC17F1B4F @default.
- Q63338654 P580 Q63338654-5861698C-0C82-4428-B400-2FE35312DE80 @default.
- Q63338654 P582 Q63338654-A73F21EB-62EC-4D4A-8AAC-C87F3FCCBDC2 @default.
- Q63338654 P6099 Q63338654-4A12E75D-14E7-44B9-A81C-6869F0A9FF9F @default.
- Q63338654 P6153 Q63338654-04D921C9-F452-4DC5-9D42-EFB7DDDE6240 @default.
- Q63338654 P6153 Q63338654-1649AA10-55C7-43EF-9221-A13562F38E3F @default.
- Q63338654 P6153 Q63338654-30A13542-E79B-4677-9C05-070861BE0EA7 @default.
- Q63338654 P6153 Q63338654-46F392E2-4B52-44BE-BE67-E62575D84995 @default.
- Q63338654 P6153 Q63338654-736C9B69-9696-4BC4-8700-A5C6E2B12720 @default.
- Q63338654 P6153 Q63338654-7543D641-2B2D-4310-A94E-BB3F373ECD22 @default.
- Q63338654 P6153 Q63338654-911F7AAE-E3D6-41AA-991A-4A0931069B8A @default.
- Q63338654 P6153 Q63338654-E356E08F-9598-4DF4-9C1C-91229BB60089 @default.
- Q63338654 P6153 Q63338654-F2E13C39-FC43-480C-8C18-246B50534DA7 @default.
- Q63338654 P8363 Q63338654-1A27E403-52CF-42D8-A044-CCED9FE07BFF @default.
- Q63338654 P859 Q63338654-46ED793D-9162-4D9F-B4A5-0EBC81ED7D4C @default.
- Q63338654 P1132 "+181" @default.
- Q63338654 P1476 "Multi-Center, Randomized, Placebo-Controlled Phase II Study of Regorafenib in Combination With FOLFIRI Versus Placebo With FOLFIRI as Second-Line Therapy in Patients With Metastatic Colorectal Cancer" @default.
- Q63338654 P17 Q27 @default.
- Q63338654 P17 Q30 @default.
- Q63338654 P2899 "+18" @default.
- Q63338654 P3098 "NCT01298570" @default.
- Q63338654 P31 Q30612 @default.
- Q63338654 P4844 Q238512 @default.
- Q63338654 P4844 Q412197 @default.
- Q63338654 P580 "2011-04-07T00:00:00Z" @default.
- Q63338654 P582 "2016-11-15T00:00:00Z" @default.
- Q63338654 P6099 Q42824440 @default.
- Q63338654 P6153 Q153265 @default.
- Q63338654 P6153 Q213439 @default.
- Q63338654 P6153 Q30270311 @default.
- Q63338654 P6153 Q309331 @default.
- Q63338654 P6153 Q33122159 @default.
- Q63338654 P6153 Q49210 @default.
- Q63338654 P6153 Q500606 @default.
- Q63338654 P6153 Q5044932 @default.
- Q63338654 P6153 Q621043 @default.
- Q63338654 P8363 Q78089383 @default.
- Q63338654 P859 Q7865231 @default.